SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

TG Therapeutics Reports Encouraging Early Phase 1 Cell Therapy Results

The company reported encouraging early results from a Phase 1 trial of its experimental cell therapy in patients with progressive multiple sclerosis.

TGTX

Related stories